CRE TBM is a leading genetic laboratory specializing in pre-clinical research for translational biology and medicine. Our team of passionate scientists leverages advanced technologies to provide comprehensive services, including genetic analysis, cellular and molecular biology assays, disease modeling, biomarker discovery, and high-throughput screening. We partner with pharmaceutical, biotech, and academic institutions to accelerate drug discovery, reduce development costs, and improve clinical trial success rates. We are committed to delivering high-quality data, personalized scientific support, and efficient project management to empower your journey from bench to bedside.
CRE TBM ltd Declaration
Proposal
provides comprehensive pre-clinical research services designed to accelerate drug discovery and development. Our team of highly qualified scientists and technicians possesses extensive experience in:
- Genetic analysis: Gene editing, sequencing, and expression studies
- Cellular and molecular biology: In vitro and ex vivo assays for target validation, drug potency, and mechanism of action
- Disease modeling: Development and utilization of relevant cell and animal models
- Biomarker discovery and validation: Identification of predictive biomarkers for patient selection and therapeutic response
- High-throughput screening: Efficient identification of lead compounds for further development
We are committed to providing high-quality data, personalized scientific support, and efficient project management to ensure the success of your pre-clinical research programs.
Departments Overview
IMMUNOLOGY
We investigate immune responses in various contexts, including autoimmune diseases, infectious diseases, and cancer. By employing cutting-edge techniques and innovative approaches, our team aims to develop new diagnostics, vaccines, and therapies to the broader field of immunology.
MEDICAL CANNABIS
We focus on clinical trials, pharmacological studies, and developing treatments for chronic pain, PTSD, epilepsy, and anxiety disorders. By leveraging cutting-edge technology and collaborating with global experts, we aim to advance medical cannabis applications and improve patient care.
MOLECULAR PHYSIOLOGY AND GENETIC
We conduct cutting-edge research to understand disease pathogenesis, identify genetic markers, and develop targeted therapies. Our work aims to advance precision medicine, offering personalized treatment solutions and improving patient outcomes.
DATA SCIENCE
We specialize in data-driven research, predictive modeling, and bioinformatics. By transforming data into actionable insights, we support innovative discoveries and enhance the effectiveness of our research across all scientific disciplines.
Tailored Solutions
We understand that each company has unique research needs. We are committed to working collaboratively with you to develop a customized pre-clinical research plan that aligns with your specific goals and timelines.
Customer centricity
We prioritize building strong client relationships based on open communication and mutual trust. All information entrusted to us, from project details to research findings, remains strictly confidential. We understand the sensitivity of your work and adhere to the highest ethical standards to ensure your intellectual property and competitive edge are always protected.